17 marzo 2013

Araclon Biotech Ltd. Describes Research in Alzheimer Disease .

Published in Health and Medicine .


2013 MAR 1 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Current study results on Neurodegenerative Diseases have been published. According to news reporting originating from Logrono, Spain, by NewsRx correspondents, research stated, "Alzheimer's disease is characterized by the abnormal aggregation of amyloid-ß (Aß)1-40 and Aß1-42 peptides into fibrils. In this work, we analyzed the kinetics of Aß1-40 and Aß1-42 fibril formation in vitro using Thioflavin T fluorescence."

Our news editors obtained a quote from the research from Araclon Biotech Ltd., "We synthesized high-purity peptides and performed a...

...

■Purchase this article for only $3.00


José Luis García Sabrido ha atendido al Presidente Venezolano y a Fidel Castro .